Opsidio is Biotechnology in United States that focus on severe asthma business. Founded in 2013. They cover business area such as monoclonal, patient, fibrotic and allergic disease, Stem Cell Factor, SCF, profibrotic cytokine, doctor, fibrotic and remodeling disease, idiopathic pulmonary fibrosis, chronic kidney disease, systemic sclerosis, severe asthma.
2013
( 11 years old in 2024 )
Severe Asthma
-
223 Ladbroke Road
Bryn Mawr, PA 19010
United States
Private
monoclonalpatientfibrotic and allergic diseaseStem Cell FactorSCFprofibrotic cytokinedoctorfibrotic and remodeling diseaseidiopathic pulmonary fibrosischronic kidney diseasesystemic sclerosissevere asthma
* We use standard office opening hours in near Opsidio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Opsidio is Biotechnology business from United States that founded in 2013 (11 years old in 2024), Opsidio business is focusing on Severe Asthma.
Opsidio headquarter office and corporate office address is located in 223 Ladbroke Road Bryn Mawr, PA 19010 United States.
Opsidio was founded in United States.
In 2024, Opsidio is currently focus on severe asthma sector.
Above is snippet of Google Trends for "severe asthma" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Opsidio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
